Nutrien Ltd. filings document the disclosure record of a Canadian crop inputs and services company that furnishes Form 6-K reports and annual disclosure materials as a Form 40-F filer. The filings include annual reports, Management’s Discussion and Analysis, audited and interim financial statements, notes to the financial statements, Annual Information Form materials and exhibits incorporated into registration statements.
The record covers Nutrien’s operating segments, market environment, capital management, governance and key enterprise risks. It also documents proxy circular matters, director elections, auditor appointments, executive compensation advisory votes, dividend declarations, normal course issuer bid disclosures and supply-chain compliance reporting through its Modern Slavery Report.
Nutrien Ltd. plans a renewed share repurchase program under a normal course issuer bid, allowing it to buy back up to 24,057,066 common shares, or five percent of its 481,141,322 shares outstanding as of February 17, 2026. Purchases may occur on the TSX, NYSE or other permitted trading systems between March 3, 2026 and the earlier of March 2, 2027 or completion of the program, and repurchased shares will be cancelled. Daily TSX purchases are generally capped at 430,107 shares, reflecting 25 percent of recent average daily volume. Under its prior program, Nutrien had already repurchased 8,708,901 shares at a weighted-average price of US$58.56, for a total of US$510,031,461, through open market purchases.
Nutrien Ltd. has scheduled its next annual meeting of security holders as a virtual event on May 6, 2026. Shareholders of record as of March 18, 2026 will be entitled to receive notice of the meeting and to vote.
The company will use notice-and-access for both registered and beneficial holders, meaning proxy materials will be delivered electronically, with no stratification criteria applied. Nutrien will not send proxy materials directly to non-objecting beneficial owners but will pay for delivery to objecting beneficial owners.
Nutrien Ltd. reported much stronger results for 2025, driven by higher fertilizer prices and solid volumes across its Potash, Nitrogen and Retail businesses. Full-year sales reached $26.9 billion, up 4% from 2024, while gross margin rose 11% to $8.3 billion. Net earnings climbed to $2.3 billion, compared with $0.7 billion a year earlier, and diluted net earnings per share increased to $4.66 from $1.36. Adjusted EBITDA grew 13% to $6.0 billion and adjusted net earnings per share rose 31% to $4.56, reflecting stronger underlying operations.
In the fourth quarter, net earnings were $0.58 billion, or $1.18 per diluted share, and adjusted EBITDA was $1.28 billion with adjusted EPS of $0.83. Results benefited from higher potash net selling prices, increased potash volumes and improved upstream fertilizer performance, partly offset by lower Nitrogen volumes and softer Retail earnings. Net income also included a gain on the sale of Nutrien’s 50% investment in Profertil.
For 2026, Nutrien targets Retail adjusted EBITDA of $1.75 billion to $1.95 billion, potash sales of 14.1 to 14.8 million tonnes, nitrogen sales of 9.2 to 9.7 million tonnes and capital expenditures of $2.0 to $2.1 billion, assuming an effective tax rate on adjusted net earnings of 24% to 26%.
Nutrien Ltd. reported much stronger results for 2025, driven by higher fertilizer prices and solid volumes across its Potash, Nitrogen and Retail businesses. Full-year sales reached $26.9 billion, up 4% from 2024, while gross margin rose 11% to $8.3 billion. Net earnings climbed to $2.3 billion, compared with $0.7 billion a year earlier, and diluted net earnings per share increased to $4.66 from $1.36. Adjusted EBITDA grew 13% to $6.0 billion and adjusted net earnings per share rose 31% to $4.56, reflecting stronger underlying operations.
In the fourth quarter, net earnings were $0.58 billion, or $1.18 per diluted share, and adjusted EBITDA was $1.28 billion with adjusted EPS of $0.83. Results benefited from higher potash net selling prices, increased potash volumes and improved upstream fertilizer performance, partly offset by lower Nitrogen volumes and softer Retail earnings. Net income also included a gain on the sale of Nutrien’s 50% investment in Profertil.
For 2026, Nutrien targets Retail adjusted EBITDA of $1.75 billion to $1.95 billion, potash sales of 14.1 to 14.8 million tonnes, nitrogen sales of 9.2 to 9.7 million tonnes and capital expenditures of $2.0 to $2.1 billion, assuming an effective tax rate on adjusted net earnings of 24% to 26%.
Nutrien Ltd. is increasing cash returns to shareholders by raising its quarterly dividend and planning a new share repurchase program. The Board declared a quarterly dividend of US$0.55 per share, payable on April 16, 2026 to shareholders of record on March 31, 2026, an increase of about one percent from the prior dividend and equal to an annualized US$2.20 per share.
The Board also approved the purchase of up to five percent of issued and outstanding common shares over a twelve-month period through a normal course issuer bid, subject to acceptance by the Toronto Stock Exchange. The dividend will be paid in Canadian or US dollars depending on shareholder residency and intermediaries, with options to elect currency and direct deposit. All dividends are designated as eligible dividends under Canadian tax law.
Nutrien Ltd. is increasing cash returns to shareholders by raising its quarterly dividend and planning a new share repurchase program. The Board declared a quarterly dividend of US$0.55 per share, payable on April 16, 2026 to shareholders of record on March 31, 2026, an increase of about one percent from the prior dividend and equal to an annualized US$2.20 per share.
The Board also approved the purchase of up to five percent of issued and outstanding common shares over a twelve-month period through a normal course issuer bid, subject to acceptance by the Toronto Stock Exchange. The dividend will be paid in Canadian or US dollars depending on shareholder residency and intermediaries, with options to elect currency and direct deposit. All dividends are designated as eligible dividends under Canadian tax law.
BlackRock, Inc. filed an amended ownership report showing it beneficially owns 23,787,129 shares of Nutrien Ltd. common stock, representing 4.9% of the class as of the reported date. BlackRock reports sole voting power over 22,161,123 shares and sole dispositive power over 23,787,129 shares, with no shared voting or dispositive power.
The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Nutrien. It also notes that various underlying persons have rights to dividends or sale proceeds, but no individual person has more than five percent of the total outstanding common shares.
BlackRock, Inc. filed a Schedule 13G reporting beneficial ownership of 24,820,750 shares of Nutrien Ltd. (NTR), representing 5.1% of the common stock as of the event date 09/30/2025.
BlackRock reports sole voting power over 22,762,839 shares and sole dispositive power over 24,820,750 shares, with no shared voting or dispositive power. The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.